Ikarian Capital »

Eliem Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Eliem Therapeutics (ELYM) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $891k 175k 5.09
2024-06-30 $711k 100k 7.11

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Eliem Therapeutics

RA Capital Management
Deep Track Capital
Henderson Group
Samsara BioCapital
Boxer Capital
BlackRock
Affinity Asset Advisors
T. Rowe Price Associates
Geode Capital Management
Driehaus Capital Management
Point72 Asset Management
Nan Fung Group Holdings
BlackRock
Vanguard Group
Northern Trust

View all funds holding Eliem Therapeutics